Skip to main contentSkip to navigation
Ovarian Cancer Research Alliance
Research Exchange
Donate

Investigator

Andrea Erxleben

Ollscoil Na Gaillimhe University Of Galway

AEAndrea Erxleben
Papers(1)
Multiaction Pt(IV) Co…
Collaborators(2)
Isolda Romero-CanelonAlan M. Jones
Institutions(2)
Ollscoil Na Gaillimhe…University Of Birming…

Papers

Multiaction Pt(IV) Complexes: Cytotoxicity in Ovarian Cancer Cell Lines and Mechanistic Studies

Ovarian cancer has the worst case-to-fatality ratio of all gynecologic malignancies. The main reasons for the high mortality rate are relapse and the development of chemoresistance. In this paper, the cytotoxic activity of two new multiaction platinum(IV) derivatives of cisplatin and oxaliplatin in a panel of ovarian cancer cells is reported.

72Works
1Papers
2Collaborators
Cell Line, TumorColorectal NeoplasmsOvarian NeoplasmsDrug Screening Assays, AntitumorApoptosis
Links & IDs
0000-0002-7309-8972
Ovarian Cancer Research Alliance

A global leader in the fight against gynecologic cancer

LIVING LAB
Join the Living LabOur TeamGovernance & EthicsSocial Media Toolkit
DISCOVERY LAB
Discovery LabHow It WorksUpcoming WebinarsContribute Data
ABOUT
About OCRAGet InvolvedMake a DonationContact Us

© 2025 Ovarian Cancer Research Alliance, Inc.

PrivacyTermsAccessibility